You think Santa can stop the biotech deal making train? Think again. A handful of companies couldn’t wait for the New Year—or next week’s JP Morgan Healthcare conference—to announce their latest wheeling and dealing. We recap the Christmas deal spree below.>> Johnson & Johnson picked up licensing rights to LegoChem Biosciences’ Trop2 directed antibody drug […]
